The news comes on the heels of a recent decision from the FDA recommending a possible annual, bivalent COVID-19 vaccine for the public. Monovalent vaccines, the CDC’s report found, have shown “waning protection … against hospitalization.”
Researchers examined the immunity of bivalent vaccine recipients in different regions across the U.S. and were able to observe that bivalent recipients had “slightly higher protection against infection and significantly higher protection against death” than those who had received monovalent vaccinations.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
